They may have plans to reduce the skyrocketing cost of prescription drugs, but neither candidate's proposals thus far look likely to provide substantial relief.
And one major reason is the power of the drug lobby.
Kaiser Health News reported that while Hillary Clinton does have an extensive proposal to tackle "unjustified price hikes for long-available drugs," as well as an additional proposal about high drug prices in general, Donald Trump hasn't addressed the problem with specifics other than to advocate legislative action that would let Medicare negotiate drug prices for its clients.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
